Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X
Validation of Modaplex POLE mutation assay in endometrial carcinoma
VIRCHOWS ARCHIV 483 787-794. .
-
Samain, R; Maiques, O; Monger, J; Lam, H; Candido, J; George, S; Ferrari, N; Kohihammer, L; Lunetto, S; Varela, A; Orgaz, JL; VILARDELL, F; Olsina, JJ; Matias-Guiu, X; Sarker, D; Biddle, A; Balkwill, FR; Eyles, J; Wilkinson, RW; Kocher, HM; Calvo, F; Wells, CM; Sanz-Moreno, V
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
Science Advances 9 -. .
-
Berek, JS; Matias-Guiu, X; FIGO Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm
Response: FIGO staging of endometrial cancer: 2023
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 163 331-331. .
-
Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science 10 -. .
-
Berek, JS; Matias-Guiu, X; Creutzberg, C; Fotopoulou, C; Gaffney, D; Kehoe, S; Lindemann, K; Mutch, D; Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm
FIGO staging of endometrial cancer: 2023
Journal of Gynecologic Oncology 34 -. .
-
Cassier PA; Navaridas R; Bellina M; Rama N; Ducarouge B; Hernandez-Vargas H; Delord JP; Lengrand J; Paradisi A; Fattet L; Garin G; Gheit H; Dalban C; Pastushenko I; Neves D; Jelin R; Gadot N; Braissand N; Léon S; Degletagne C; Matias-Guiu X; Devouassoux-Shisheboran M; Mery-Lamarche E; Allard J; Zindy E; Decaestecker C; Salmon I; Perol D; Dolcet X; Ray-Coquard I; Blanpain C; Bernet A; Mehlen P
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature 620 409-416. .
-
Gaillard, T; Schwameis, R; Laas-Faron, E; Eisenberg-Nissim, T; Matias-Guiu, X; Creutzberg, CL; Ledermann, J; Planchamp, F; Concin, N
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 33 1181-1184. .
-
Pizarro, D; Romero, I; Perez-Mies, B; Redondo, A; Caniego-Casas, T; Carretero-Barrio, I; Cristobal, E; Gutierrez-Pecharroman, A; Santaballa, A; D'Angelo, E; Hardisson, D; Vieites, B; Matias-Guiu, X; Estevez, P; Guerra, E; Prat, J; Poveda, A; Lopez-Guerrero, JA; Palacios, J
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .
-
Berek, JS; Matias-Guiu, X; Creutzberg, C; Fotopoulou, C; Gaffney, D; Kehoe, S; Lindemann, K; Mutch, D; Concin, N; Endometrial Canc Staging Subcomm; FIGO Womens Canc Comm
FIGO staging of endometrial cancer: 2023
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 162 383-394. .
-
Crosas-Molist E; Graziani V; Maiques O; Pandya P; Monger J; Samain R; George SL; Malik S; Salise J; Morales V; Le Guennec A; Atkinson RA; Marti RM; Matias-Guiu X; Charras G; Conte MR; Elosegui-Artola A; Holt M; Sanz-Moreno V
AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.
Nature Communications 14 2740-2740. .
-
Lombaers MS; Cornel KMC; Visser NCM; Bulten J; Küsters-Vandevelde HVN; Amant F; Boll D; Bronsert P; Colas E; Geomini PMAJ; Gil-Moreno A; van Hamont D; Huvila J; Krakstad C; Kraayenbrink AA; Koskas M; Mancebo G; Matías-Guiu X; Ngo H; Pijlman BM; Vos MC; Weinberger V; Snijders MPLM; van Koeverden SW; Enitec-Consortium; Haldorsen IS; Reijnen C; Pijnenborg JMA
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.
Cancers 15 -. .
-
Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Perramon-Güell A; Megino-Luque C; Llobet-Navas D; Matias-Guiu X; Egea J; Encinas M; Bardia L; Colombelli J; Dolcet X
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.
Cancer Communications 43 620-624. .
Projectes
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
